News from aethlon medical, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 01, 2023, 15:51 ET Aethlon Medical to Present at the 13th Annual LD Micro Invitational

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening...

May 22, 2023, 08:01 ET Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening...

Feb 13, 2023, 16:15 ET Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening...

Feb 06, 2023, 10:50 ET Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023

Aethlon Medical, Inc. (NASDAQ: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today...

Jan 31, 2023, 08:01 ET Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, announced...

Jan 30, 2023, 08:01 ET Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious diseases, today...

Nov 14, 2022, 16:15 ET Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening...

Nov 02, 2022, 14:43 ET Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today...

Sep 06, 2022, 08:01 ET Aethlon Medical to Present at Two Investor Conferences in September

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening...

Aug 09, 2022, 16:15 ET Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening...

Aug 03, 2022, 12:47 ET Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today...

Jul 28, 2022, 14:01 ET Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening...

Jul 11, 2022, 08:01 ET Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening...

Jun 28, 2022, 16:15 ET Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening...

Jun 21, 2022, 08:01 ET Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today...

May 24, 2022, 16:21 ET Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening...

May 02, 2022, 08:01 ET Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening...

Mar 28, 2022, 08:01 ET Aethlon Medical, Inc. Appoints Angela Rossetti to Board of Directors

Aethlon Medical, Inc. ("Aethlon") (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ...

Feb 14, 2022, 16:15 ET Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious diseases, today...

Jan 31, 2022, 08:01 ET Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today...

Nov 09, 2021, 16:15 ET Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious diseases, today...

Nov 02, 2021, 08:02 ET Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today...

Oct 12, 2021, 08:01 ET Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today...

Sep 30, 2021, 08:02 ET Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today...

Sep 07, 2021, 08:01 ET Aethlon Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening...